Naratriptan
Naramig contains naratriptan (as hydrochloride), which belongs to a group of medicines called triptans (also known as 5-HT1 receptor agonists).
Naramig is used to treat migraine attacks.
Before you start taking Naramig, tell your doctor or pharmacist:
In very rare cases, patients have had serious heart problems after taking Naramig, even though they had no signs of heart disease before.
If any of the above apply to you, it may mean you have an increased risk of heart problems.
Tell your doctor. Your doctor will carry out a heart examination before prescribing Naramig.
You may also be allergic to Naramig.
If you know you are allergic to an antibiotic but are not sure if it is a sulphonamide, tell your doctor or pharmacist before taking Naramig.
Patients who get migraines may be more likely to have strokes or other problems with their blood vessels.
Naramig should only be used for migraines that have been diagnosed by a doctor.
Tell your doctor if you get a headache which is unusual for you before taking Naramig. Your doctor may want to examine you to make sure that the headache is not caused by another illness.
Taking Naramig for a long time may make your headaches worse.
Tell your doctor if this happens to you. Your doctor may want you to stop taking Naramig.
These symptoms may be severe but are usually short-lived.
If they do not go away quickly or get worse, do not take any more Naramig and tell your doctor straight away (see also section 4).
Tell your doctor before taking Naramig (see also section “Naramig with other medicines”).
Tell your doctor or pharmacist about all the medicines you are taking, or have recently taken, including those you have bought without a prescription, including herbal medicines.
Some medicines cannot be taken with Naramig and some may cause side effects when taken with Naramig.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
There is limited information on the use of Naramig in pregnancy. Your doctor may advise you not to take Naramig if you are pregnant.
Do not breast-feed for 24 hours after taking Naramig. Any breast milk produced during this time should be discarded.
Drowsiness may be a symptom of migraine or a side effect of Naramig. If this happens, do not drive or use machines.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Naramig contains less than 1 mmol sodium (23 mg) per tablet, which is essentially sodium-free.
The safety and effectiveness of naratriptan when given before the onset of a migraine aura have not been established.
Always take Naramig exactly as your doctor has told you. If you are not sure, ask your doctor or pharmacist.
The usual dose for adults (aged 18-65 years) is one 2.5 mg tablet. Swallow the tablet whole with water.
Naramig is not recommended for children and adolescents under 18 years or adults over 65 years.
Naramig can be taken at any stage of a migraine attack but it is most effective when taken as soon as possible after the start of the attack.
If you have no kidney or liver problems, you can take a second tablet after 4 hours.
Do not take more than 2 tablets in 24 hours.
If you have kidney or liver problems, do not take more than 1 tablet in 24 hours.
Do not take another tablet during the same attack.
If Naramig does not relieve your migraine, tell your doctor or pharmacist.
Do not take more than 2 tablets in 24 hours.
Taking too much Naramig may cause side effects.
If you have taken more than 2 tablets in 24 hours, tell your doctor or pharmacist for advice.
If you have any further questions on the use of this product, ask your doctor or pharmacist.
Like all medicines, Naramig can cause side effects, although not everybody gets them.
An allergic reaction (such as wheezing, swelling of the face, lips, tongue or throat, and difficulty breathing) occurs rarely (less than 1 in 1000 patients).
If you get any of these symptoms after taking Naramig, do not take any more and tell your doctor straight away.
(may affect up to 1 in 10 people)
(may affect up to 1 in 100 people)
(may affect up to 1 in 1,000 people)
(may affect up to 1 in 10,000 people)
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly via the national reporting system listed in the “Yellow Card Scheme” (www.mhra.gov.uk/yellowcard).
By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton after EXP.
The expiry date refers to the last day of that month.
Store in a cool, dry place, below 30°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Naramig tablets are green, film-coated, D-shaped, with “GX CE5” engraved on one side. They are available in packs of 2, 4 and 6 tablets in blisters.
Not all pack sizes may be marketed.
GlaxoSmithKline (Ireland) Limited
12 Riverwalk
Citywest Business Campus
Dublin 24
Ireland.
Delpharm Poznań Spółka Akcyjna
ul. Grunwaldzka 189
60-322 Poznań
For further information, contact the Marketing Authorisation Holder:
GSK Services Sp. z o.o.
ul. Rzymowskiego 53
02-697 Warszawa
tel. (0-22) 576-90-00
Date of last revision of the leaflet: June 2022
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.